Delayed Surgery after Neoadjuvant Treatment for Rectal Cancer Does Not Lead to Impaired Quality of Life, Worry for Cancer, or Regret

Delayed Surgery after Neoadjuvant Treatment for Rectal Cancer Does Not Lead to Impaired Quality of Life, Worry for Cancer, or Regret

Non operative management of complete clinical responders after neoadjuvant treatment for rectal cancer enjoys an increasing popularity because of the increased functional outcome results. Even a near complete response can evolve in a cCR, and therefore further delaying response assessment is accepte...

Full description

Bibliographic Details
Main Authors:	Vincent Maurice Meyer, Richtje R Meuzelaar, Yvonne Schoenaker, Jan-Willem de Groot, Edwin de Boer, Onno Reerink, Wouter de Vos tot Nederveen Cappel, Geerard L Beets, Henderik L van Westreenen
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Cancers
Subjects:	rectal cancer watch and wait neo-adjuvant treatment non operative management
Online Access:	https://www.mdpi.com/2072-6694/13/4/742

Similar Items

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Kazushige Kawai, et al.
Published: (2017-04-01)

Watch and Wait Approach for Rectal Cancer Following Neoadjuvant Treatment: The Experience of a High Volume Cancer Center
by: Daniela Rega, et al.
Published: (2021-08-01)

Current status of active surveillance in prostate cancer
by: Mun Su Chung, et al.
Published: (2016-01-01)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
by: Federica Papaccio, et al.
Published: (2020-12-01)

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma
by: Angela Y. Jia, et al.
Published: (2019-08-01)

Longitudinal monitoring of the course of depressive disorders: Careful monitoring of the course of depressive episode
by: Kostić Milutin, et al.
Published: (2020-01-01)

A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
by: Sang Hun Song, et al.
Published: (2021-01-01)

Post-Neoadjuvant Surveillance and Surgery as Needed Compared with Post-Neoadjuvant Surgery on Principle in Multimodal Treatment for Esophageal Cancer: A Scoping Review
by: Julian Hipp, et al.
Published: (2021-01-01)

Analysis of long-term oncological results of clinical versus pathological responses after neoadjuvant treatment in locally advanced rectal cancer
by: Mariana F. Coraglio, et al.
Published: (2020-11-01)

Active surveillance of renal masses: an analysis of growth kinetics and clinical outcomes stratified by radiological characteristics at diagnosis
by: Ryan Dorin, et al.
Published: (2014-10-01)

Scrappy the Bandit and the Outlaw Wolf
by: Track, Allison Natalie
Published: (2006)

Super active surveillance for low-risk prostate cancer | Opinion: No
by: Saum Ghodoussipour, et al.

Super active surveillance for low-risk prostate cancer | Opinion: Yes
by: Leonardo O. Reis, et al.

MRI should be routine for all patients with localized prostate cancer? | Opinion: No
by: Joel B. Nelson

MRI should be routine for all patients with localized prostate cancer? | Opinion: Yes
by: Ronaldo Hueb Baroni

Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era
by: Mun Su Chung, et al.
Published: (2021-07-01)

Computertomography-Based Prediction of Complete Response Following Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
by: Marina Maslova, et al.
Published: (2021-05-01)

The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance
by: Chang Wook Jeong, et al.
Published: (2014-12-01)

Ultrasound in active surveillance for low-risk papillary thyroid cancer: imaging considerations in case selection and disease surveillance
by: Sangeet Ghai, et al.
Published: (2021-09-01)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
by: Wan Song, et al.
Published: (2019-11-01)

The Mind
by: Leonardo de Oliveira Reis, et al.
Published: (2015-02-01)

Active surveillance for nonmuscle invasive bladder cancer
by: Makito Miyake, et al.
Published: (2016-06-01)

Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up
by: Ji Yong Ha, et al.
Published: (2017-05-01)

Predictors of complete response and disease recurrence following chemoradiation for rectal cancer
by: Danielle S. Bitterman, et al.
Published: (2015-12-01)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
by: Hanfeng Wang, et al.
Published: (2017-09-01)

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
by: Min Ji Jeon, et al.
Published: (2021-08-01)

Novel approaches to treatment of locally advanced rectal cancer
by: A. A. Kachmazov, et al.
Published: (2020-12-01)

Active surveillance in intermediate risk prostate cancer: is it safe?
by: Nishanth Krishnananthan, et al.
Published: (2016-06-01)

Monitoring cancer stem cells: insights into clinical oncology
by: Lin SC, et al.
Published: (2016-02-01)

Active surveillance in intermediate risk prostate cancer: is it safe?
by: Henk G. van der Poel, et al.
Published: (2016-06-01)

Midterm MRI Follow-Up of Untreated Enchondroma and Atypical Cartilaginous Tumors in the Long Bones
by: Claudia Deckers, et al.
Published: (2021-08-01)

Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies
by: Malte W. Vetterlein, et al.
Published: (2016-07-01)

Re-staging and follow-up of rectal cancer patients with MR imaging when “Watch-and-Wait” is an option: a practical guide
by: Inês Santiago, et al.
Published: (2021-08-01)

Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis
by: Giuditta Chiloiro, et al.
Published: (2021-05-01)

Advances in the treatment of locally advanced rectal cancer
by: Fadwa Ali, et al.
Published: (2021-01-01)

Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence
by: Karen Benezery, et al.
Published: (2020-09-01)

Effectiveness of endoscopic totally extraperitoneal (TEP) hernia correction for clinically occult inguinal hernia (EFFECT): study protocol for a randomized controlled trial
by: Marleen M. Roos, et al.
Published: (2018-06-01)

Comparison between watchful waiting strategy and early initiation of renal replacement therapy in the critically ill acute kidney injury population: an updated systematic review and meta-analysis
by: Jia-Jin Chen, et al.
Published: (2020-03-01)

Development of a clinical trial to determine whether watchful waiting is an acceptable alternative to surgical repair for patients with oligosymptomatic incisional hernia: study protocol for a randomized controlled trial
by: Lauscher Johannes C, et al.
Published: (2012-02-01)

Asymptomatic Patients with Severe Aortic Stenosis and the Impact of Intervention
by: Mevlüt Çelik, et al.
Published: (2021-03-01)